NCT06961123 Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth
| NCT ID | NCT06961123 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Low Apgar Scores |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2025-03-11 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2025-03-11 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to identify high-risk factors associated with low Apgar scores, implement proactive interventions to reduce their occurrence, and analyze neonatal resuscitation procedures and systemic treatment during hospitalization. This aims to provide evidence-based references for improving the resuscitation and medical management of newborns with low Apgar scores, thereby enhancing clinical care capabilities. Additionally, continuous follow-up management and timely intervention guidance will be provided to these infants to optimize their long-term prognosis.
Eligibility Criteria
Inclusion Criteria: * Retrospective cohort inclusion criteria: Newborns born between January 1, 2006 and before the start of the project at Peking University Third Hospital with Apgar scores ≤ 7 at 1 minute, 5 minutes, or 10 minutes. Prospective cohort inclusion criteria: Newborns born at Peking University Third Hospital between the start of the project and December 31, 2027, with an Apgar score of ≤ 7 at 1 minute, 5 minutes, or 10 minutes. Exclusion Criteria: * There are serious congenital malformations that affect physical and neurological development, and family members refuse to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06961123 clinical trial?
This trial is open to participants of all sexes, studying Low Apgar Scores. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06961123 currently recruiting?
Yes, NCT06961123 is actively recruiting participants. Contact the research team at wangqing01s@163.com for enrollment information.
Where is the NCT06961123 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06961123 clinical trial?
NCT06961123 is sponsored by Peking University Third Hospital. The trial plans to enroll 600 participants.